From Chemistry to Biology: Zinc(II)–1,10-Phenanthroline-5,6-dione Complex Exhibits Potent Activity against Mammalian Stages of Trypanosoma cruzi with Controlled Host Cell Toxicity

Abstract Chagas disease, caused by Trypanosoma cruzi, affects 6–7 million people worldwide and causes ∼12,000 deaths annually. Treatments are limited to benznidazole and nifurtimox, both associated with toxicity, adverse effects, and frequent treatment discontinuation, highlighting the need for new therapeutic strategies. Here, a coordination compound was synthesized and evaluated against cell-derived trypomastigotes and intracellular amastigotes of T. cruzi. The compound, [Zn(1,10-phenanthroline-5,6-dione)3](ClO4)2·6H2O (Zn-phendione), consists of a hexacoordinated Zn(II) center bound to three phendione ligands, forming a dicationic complex. The anti-T. cruzi activity of Zn-phendione was initially evaluated in trypomastigotes, in which it reduced parasite viability in a dose-dependent manner after 24 h, with an LD50 of 3.30 nM. This activity was higher than that of the free ligand phendione (LD50 = 7.56 nM) and was 388-fold greater than benznidazole (LD50 = 1,280 nM), whereas the zinc salt alone showed no activity. Zn-phendione-treated trypomastigotes, as observed by optical and scanning electron microscopy, exhibited pronounced morphological alterations, including cell twisting, swelling, and partial or complete loss of the unique flagellum. Notably, 1-h exposure to Zn-phendione decreased trypomastigote infectivity by ∼50% at the LD50. Moreover, Zn-phendione dose-dependently inhibited intracellular amastigote replication after 72 h (IC50 = 36 nM), outperforming benznidazole (IC50 = 210 nM), while showing no toxicity to the host cells used for amastigote maintenance. For trypomastigotes, 24-h exposure resulted in selectivity index (SI) values of >312.5 for benznidazole and 64,800 for Zn-phendione, whereas for amastigotes, 72-h exposure yielded SI values of >238.1 and 83.3, respectively. These findings highlight Zn-phendione as a promising candidate for the development of new therapeutic strategies against T. cruzi.

Authors

Institutions

Publication Details

Journal
ACS Omega
Published
2026-11-12
DOI
https://doi.org/10.1021/acsomega.6c08331
Primary Topic
Trypanosoma species research and implications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

From Chemistry to Biology: Zinc(II)–1,10-Phenanthroline-5,6-dione Complex Exhibits Potent Activity against Mammalian Stages of Trypanosoma cruzi with Controlled Host Cell Toxicity

Rubem F. S. Menna‐Barreto, Christiane Fernandes, André Luis Souza dos Santos, Simone S. C. Oliveira et al.
ACS Omega
Trypanosoma species research and implications
article

From Chemistry to Biology: Zinc(II)–1,10-Phenanthroline-5,6-dione Complex Exhibits Potent Activity against Mammalian Stages of Trypanosoma cruzi with Controlled Host Cell Toxicity

Rubem F. S. Menna‐Barreto, Christiane Fernandes, André Luis Souza dos Santos, Simone S. C. Oliveira, Marta H. Branquinha, Rafaela Silva-Oliveira, Luis Gabriel Wagner
article en

Abstract

Abstract Chagas disease, caused by Trypanosoma cruzi, affects 6–7 million people worldwide and causes ∼12,000 deaths annually. Treatments are limited to benznidazole and nifurtimox, both associated with toxicity, adverse effects, and frequent treatment discontinuation, highlighting the need for new therapeutic strategies. Here, a coordination compound was synthesized and evaluated against cell-derived trypomastigotes and intracellular amastigotes of T. cruzi. The compound, [Zn(1,10-phenanthroline-5,6-dione)3](ClO4)2·6H2O (Zn-phendione), consists of a hexacoordinated Zn(II) center bound to three phendione ligands, forming a dicationic complex. The anti-T. cruzi activity of Zn-phendione was initially evaluated in trypomastigotes, in which it reduced parasite viability in a dose-dependent manner after 24 h, with an LD50 of 3.30 nM. This activity was higher than that of the free ligand phendione (LD50 = 7.56 nM) and was 388-fold greater than benznidazole (LD50 = 1,280 nM), whereas the zinc salt alone showed no activity. Zn-phendione-treated trypomastigotes, as observed by optical and scanning electron microscopy, exhibited pronounced morphological alterations, including cell twisting, swelling, and partial or complete loss of the unique flagellum. Notably, 1-h exposure to Zn-phendione decreased trypomastigote infectivity by ∼50% at the LD50. Moreover, Zn-phendione dose-dependently inhibited intracellular amastigote replication after 72 h (IC50 = 36 nM), outperforming benznidazole (IC50 = 210 nM), while showing no toxicity to the host cells used for amastigote maintenance. For trypomastigotes, 24-h exposure resulted in selectivity index (SI) values of >312.5 for benznidazole and 64,800 for Zn-phendione, whereas for amastigotes, 72-h exposure yielded SI values of >238.1 and 83.3, respectively. These findings highlight Zn-phendione as a promising candidate for the development of new therapeutic strategies against T. cruzi.

ACS Omega
Universidade Federal do Rio de Janeiro (BR), Universidade Federal de Santa Catarina (BR), Fundação Oswaldo Cruz (BR)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
Good health and well-being
Trypanosoma species research and implications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon